Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis
Background Janus kinase 1 inhibitor upadacitinib is therapeutically effective for atopic dermatitis (AD). However, predictive factors for high responders to upadacitinib have not been established in real-world clinical practice.Objectives To identify predictive factors for responders to upadacitinib...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis Group
2024-12-01
|
| Edice: | Journal of Dermatological Treatment |
| Témata: | |
| On-line přístup: | https://www.tandfonline.com/doi/10.1080/09546634.2024.2310643 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|